Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Bonafide-HF3.0
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Undisclosed
Sponsor : Lindus Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Hot Flash and Night Sweat Virtual Study
Details : Bonafide-HF3.0 is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Menopause.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
March 04, 2024
Lead Product(s) : Bonafide-HF3.0
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Undisclosed
Sponsor : Lindus Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Bonafide Pollen
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Approved FDF
Sponsor : Pharmavite
Deal Size : Undisclosed
Deal Type : Acquisition
Details : Through the acquisition, Pharmavite will expand its portfolio of women's health by including Relizen (bonafide pollen), a plant-based & hormone-free supplement, which is safe to use for menopause relief.
Product Name : Relizen
Product Type : Miscellaneous
Upfront Cash : Undisclosed
November 30, 2023
Lead Product(s) : Bonafide Pollen
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Approved FDF
Sponsor : Pharmavite
Deal Size : Undisclosed
Deal Type : Acquisition
Lead Product(s) : JDS-HF
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Undisclosed
Sponsor : Nutrasource
Deal Size : Inapplicable
Deal Type : Inapplicable
Herbal Nutraceutical Supplementation on Vasomotor Symptoms in Menopausal Women
Details : JDS-HF is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Hot Flashes.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
April 14, 2023
Lead Product(s) : JDS-HF
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Undisclosed
Sponsor : Nutrasource
Deal Size : Inapplicable
Deal Type : Inapplicable